BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

425 related articles for article (PubMed ID: 33098146)

  • 1. Alternative treatment of fungal infections: Synergy with non-antifungal agents.
    Rossato L; Camargo Dos Santos M; Vitale RG; de Hoog S; Ishida K
    Mycoses; 2021 Mar; 64(3):232-244. PubMed ID: 33098146
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synergistic combinations of antifungals and anti-virulence agents to fight against Candida albicans.
    Cui J; Ren B; Tong Y; Dai H; Zhang L
    Virulence; 2015; 6(4):362-71. PubMed ID: 26048362
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combinatorial strategies for combating invasive fungal infections.
    Spitzer M; Robbins N; Wright GD
    Virulence; 2017 Feb; 8(2):169-185. PubMed ID: 27268286
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Repurposing antipsychotic drugs into antifungal agents: Synergistic combinations of azoles and bromperidol derivatives in the treatment of various fungal infections.
    Holbrook SYL; Garzan A; Dennis EK; Shrestha SK; Garneau-Tsodikova S
    Eur J Med Chem; 2017 Oct; 139():12-21. PubMed ID: 28797882
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Resistance in human pathogenic yeasts and filamentous fungi: prevalence, underlying molecular mechanisms and link to the use of antifungals in humans and the environment.
    Jensen RH
    Dan Med J; 2016 Oct; 63(10):. PubMed ID: 27697142
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antifungal Drugs: The Current Armamentarium and Development of New Agents.
    Robbins N; Wright GD; Cowen LE
    Microbiol Spectr; 2016 Oct; 4(5):. PubMed ID: 27763259
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The fungal resistome: a risk and an opportunity for the development of novel antifungal therapies.
    Reales-Calderón JA; Molero G; Gil C; Martínez JL
    Future Med Chem; 2016 Aug; 8(12):1503-20. PubMed ID: 27485839
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antifungals discovery: an insight into new strategies to combat antifungal resistance.
    Fuentefria AM; Pippi B; Dalla Lana DF; Donato KK; de Andrade SF
    Lett Appl Microbiol; 2018 Jan; 66(1):2-13. PubMed ID: 29112282
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Strategies in the discovery of novel antifungal scaffolds.
    Liu N; Wang C; Su H; Zhang W; Sheng C
    Future Med Chem; 2016 Aug; 8(12):1435-54. PubMed ID: 27463376
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antifungal adjuvants: Preserving and extending the antifungal arsenal.
    Butts A; Palmer GE; Rogers PD
    Virulence; 2017 Feb; 8(2):198-210. PubMed ID: 27459018
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current status of antifungal resistance and its impact on clinical practice.
    Alcazar-Fuoli L; Mellado E
    Br J Haematol; 2014 Aug; 166(4):471-84. PubMed ID: 24749533
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Facilitators of adaptation and antifungal resistance mechanisms in clinically relevant fungi.
    Hokken MWJ; Zwaan BJ; Melchers WJG; Verweij PE
    Fungal Genet Biol; 2019 Nov; 132():103254. PubMed ID: 31326470
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Resistance to Antifungal Drugs.
    Ben-Ami R; Kontoyiannis DP
    Infect Dis Clin North Am; 2021 Jun; 35(2):279-311. PubMed ID: 34016279
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synergistic and antagonistic drug interactions in the treatment of systemic fungal infections.
    Wambaugh MA; Denham ST; Ayala M; Brammer B; Stonhill MA; Brown JC
    Elife; 2020 May; 9():. PubMed ID: 32367801
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combination antifungal therapy: the new frontier.
    Vazquez JA
    Future Microbiol; 2007 Apr; 2(2):115-39. PubMed ID: 17661650
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [In vitro antifungal activity of voriconazole: New data after the first years of clinical experience].
    Quindós G; Carrillo-Muñoz AJ; Eraso E; Cantón E; Pemán J
    Rev Iberoam Micol; 2007 Sep; 24(3):198-208. PubMed ID: 17874856
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antifungal drug resistance in pathogenic fungi.
    Vanden Bossche H; Dromer F; Improvisi I; Lozano-Chiu M; Rex JH; Sanglard D
    Med Mycol; 1998; 36 Suppl 1():119-28. PubMed ID: 9988500
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [In vitro antifungal activity of micafungin].
    Quindós G; Eraso E; Javier Carrillo-Muñoz A; Cantón E; Pemán J
    Rev Iberoam Micol; 2009 Mar; 26(1):35-41. PubMed ID: 19463275
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antifungals.
    Campoy S; Adrio JL
    Biochem Pharmacol; 2017 Jun; 133():86-96. PubMed ID: 27884742
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synergy against fungal pathogens: working together is better than working alone.
    Musiol R; Mrozek-Wilczkiewicz A; Polanski J
    Curr Med Chem; 2014 Mar; 21(7):870-93. PubMed ID: 24350847
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.